Kallisio Expands Patient Access to Stentra™, an FDA-cleared Custom Mouthpiece for Head and Neck Cancer Radiation Therapy

Kallisio expanded its program providing patient access to Stentra custom mouthpieces intended to improve head-and-neck cancer radiation therapy. The announcement signals broader availability of a specialized treatment-support product, but provides no financial metrics, clinical outcomes, or commercial guidance.